OrbiMed’s Xtant Medical Holdings XTNT Stock Holding History

OrbiMed’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-73,114,592	Closed	-$34.4M	–	128
2025 Q1	$34.4M	Hold	73,114,592	–	–	0.83%	33
2024 Q4	$32.4M	Hold	73,114,592	–	–	0.67%	42
2024 Q3	$49.4M	Hold	73,114,592	–	–	0.9%	32
2024 Q2	$46.1M	Hold	73,114,592	–	–	0.92%	34
2024 Q1	$85.5M	Hold	73,114,592	–	–	1.57%	19
2023 Q4	$82.6M	Hold	73,114,592	–	–	1.65%	18
2023 Q3	$80.4M	Hold	73,114,592	–	–	1.73%	19
2023 Q2	$68M	Hold	73,114,592	–	–	1.24%	30
2023 Q1	$46.6M	Hold	73,114,592	–	–	0.92%	38
2022 Q4	$48.3M	Hold	73,114,592	–	–	0.92%	41
2022 Q3	$52.6K	Buy	73,114,592 +170,674	+0.2%	+$93.5K	0.98%	38
2022 Q2	$37.9K	Hold	72,943,918	–	–	0.69%	46
2022 Q1	$49.6M	Buy	72,943,918 +70,424	+0.1%	+$46.1K	0.81%	39
2021 Q4	$40.8M	Hold	72,873,494	–	–	0.52%	54
2021 Q3	$80.9M	Hold	72,873,494	–	–	0.89%	34
2021 Q2	$119M	Hold	72,873,494	–	–	1.2%	28
2021 Q1	$172M	Buy	72,873,494 +70,422	+0.1%	+$150K	1.61%	18
2020 Q4	$87.1M	Buy	72,803,072 +63,554,394	+687%	+$81.8M	0.76%	42
2020 Q3	$7.62M	Hold	9,248,678	–	–	0.1%	115
2020 Q2	$8.32M	Buy	9,248,678 +41,666	+0.5%	+$38.2K	0.12%	107
2020 Q1	$6.17M	Hold	9,207,012	–	–	0.1%	100
2019 Q4	$14.7M	Hold	9,207,012	–	–	0.21%	72
2019 Q3	$26.1M	Hold	9,207,012	–	–	0.5%	51
2019 Q2	$27.6M	Hold	9,207,012	–	–	0.44%	56
2019 Q1	$28.1M	Hold	9,207,012	–	–	0.44%	58
2018 Q4	$14.8M	Hold	9,207,012	–	–	0.28%	77
2018 Q3	$35.4M	Hold	9,207,012	–	–	0.43%	65
2018 Q2	$51.1M	Hold	9,207,012	–	–	0.61%	49
2018 Q1	$72.6M	Buy	9,207,012 +8,810,813	+2,224%	+$58M	0.91%	38
2017 Q4	$272K	Buy	396,199 +356,579	+900%	+$2.81M	﹤0.01%	132
2017 Q3	$343K	Hold	39,620	–	–	﹤0.01%	139
2017 Q2	$314K	Hold	39,620	–	–	﹤0.01%	137
2017 Q1	$296K	Hold	39,620	–	–	﹤0.01%	135
2016 Q4	$261K	Hold	39,620	–	–	﹤0.01%	132
2016 Q3	$537K	Hold	39,620	–	–	0.01%	137
2016 Q2	$908K	Hold	39,620	–	–	0.01%	128
2016 Q1	$1.29M	Hold	39,620	–	–	0.01%	133
2015 Q4	$1.33M	Hold	39,620	–	–	0.01%	121
2015 Q3	$1.55M	Hold	39,620	–	–	0.02%	125
2015 Q2	$1.66M	Hold	39,620	–	–	0.01%	132
2015 Q1	$1.95M	Hold	39,620	–	–	0.02%	127
2014 Q4	$1.44M	Hold	39,620	–	–	0.01%	125
2014 Q3	$2.13M	Hold	39,620	–	–	0.02%	123
2014 Q2	$32.1M	Hold	39,620	–	–	0.39%	52
2014 Q1	$3.99M	Buy	39,620 +12,500	+46%	+$986K	0.05%	122
2013 Q4	$1.63M	Buy	27,120 +12,500	+85%	+$799K	0.02%	110
2013 Q3	$1.18M	Hold	14,620	–	–	0.02%	123
2013 Q2	$789K	Buy	+14,620	New	+$1.21M	0.02%	123

Other funds holding XTNT

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return